Background: In 2012, with a national HCV prevalence of 3.25% among “baby boomers” (born 1945-65), CDC recommended one-time HCV testing without regard to risk in this cohort, in addition to targeted testing for all with risk factors or clinical indications. Emergency departments (EDs) are a key venue for HCV testing because of their success in HIV screening given the populations they serve. However, few EDs have evaluated the underlining burden of known and unknown HCV infections in their populations before implementing an HCV testing program. Since the Hopkins ED has conducted serosurveys on HCV and HIV for the past two decades, we sought to determine the overall burden of undocumented HCV infection in our inner-city ED in order to provide guidance for an ED-based HCV testing program.
Methods: An 8-week seroprevalence study with identity-unlinked methodology was conducted in an urban adult ED in 2013. All patients with blood specimens as part of their clinical procedures were included. Demographic and clinical information including documented HCV infection was obtained from administrative datasets or from electronic medical records. Anti-HCV antibody testing was performed on excess blood samples by HCV EIA after de-identification.
Results: Of 4,687 patients, 650 (14%) were anti-HCV antibody positive. Of these, 203 (31%) patients did not have documented HCV infection. “Baby boomer” patients v. others had a higher overall and undocumented HCV prevalence (overall: 24.9% vs. 7.1%; unknown: 7.2% vs. 2.6%, p<0.05). Prevalence of undocumented HCV infection varied by age, gender, and race (Figure 1). Notably, the undocumented prevalence for non-Black male born after 1965 and Black men and women born between 1966 and 1977 was equal to or greater than national prevalence of 3.25% in the “baby boomer” birth cohort. Among patients with undocumented infections, 37% occurred outside the “baby boomers” cohort. Injection drug use (IDU) was reported in only 30% of patients with undocumented HCV born after 1965. If our ED adhered to the CDC guidelines, 55 (27%) patients with undocumented HCV would not be screened.
Conclusions: High seroprevalence of both known and undocumented HCV infection were observed, indicating that urban EDs could be a useful venue for HCV testing. Our data also demonstrated that high seroprevalence was also observed among subgroups of non-“baby boomer “ patients without IDU, suggesting the need to consider for modification of the CDC recommendations for HCV testing in the ED settings.
Figure 1: Prevalence of Undocumented HCV Infection by Age, Race and Gender Group in 4,687 Johns Hopkins Hospital Adult Emergency Department Patients, 2013